Editor’s Note October 17, 2011
As OneMedForum SF 2012 approaches, OneMedSentinel is on the lookout for some of the most promising companies and technologies, as well as innovative approaches to […]
STENTYS May Solve One of The Biggest Problems In Acute Coronary Syndrome
Gonzague Issenmann, CEO and co-founder of STENTYS, spoke with OneMedRadio and shared his insights on the industry and how the company has become a success.
Teribone Treats Osteoporosis With Noninvasive Systematic Approach
It was announced this week that Zosano Pharma, Inc. (Zosano) and Asahei Kasei Pharma (AKP) formed a collaboration to develop Teribone (teriparatide acetate), a transdermal patch treatment for osteoporosis.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Inovio wins prestigious Edward Jenner Poster Award for cervical cancer vaccine research
Inovio Pharmaceuticals (AMEX:INO) won the Edward Jenner Poster Award First Prize for its research to develop a therapeutic, synthetic vaccine for cancer.
Promising Medical Technologies from Leading Universities to Showcase at 5th Annual OneMedForum
Significant Advances in Translational Medicine Result from “Coulter Process”.
Fibromyalgia Treatment Re-Engineered to Reach Unmet Medical Conditions
TONIX Pharmaceuticals announced the publication of data in the peer-reviewed journal, The Journal of Rheumatology, demonstrating an improvement in core symptoms associated with FM.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his new column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Advanced Cell receives green light from independent monitoring board to move forward with US trials
Advanced Cell Technology (OTCBB:ACTC) has received approval to move forward with enrolling and treating the next set of patients.
Editor’s Note October 3, 2011
As OneMedForum SF 2012 approaches, OneMedSentinel is on the lookout for some of the most promising companies and technologies, as well as innovative approaches to […]